Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex add-on for chemotherapy-induced nausea and vomiting
2004-003824-36Phase 3Active
- Sponsor
- Institut Català de Farmacologia
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Sativex + standard antiemetic treatment with Placebo + standard antiemetic treatment (2 arms). Primary endpoints: Primary efficacy endpoint, Late nausea and vomiting control and 1 more. Started Sep 2005; status: active.
02
Drugs
cannabidiol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2004-003824-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003824-36.